These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

616 related items for PubMed ID: 33042260

  • 1. LPA3-mediated lysophosphatidic acid signaling promotes postnatal heart regeneration in mice.
    Wang F, Liu S, Pei J, Cai L, Liu N, Liang T, Dong X, Cong X, Chun J, Chen J, Hu S, Chen X.
    Theranostics; 2020; 10(24):10892-10907. PubMed ID: 33042260
    [Abstract] [Full Text] [Related]

  • 2. Specific LPA receptor subtype mediation of LPA-induced hypertrophy of cardiac myocytes and involvement of Akt and NFkappaB signal pathways.
    Chen J, Chen Y, Zhu W, Han Y, Han B, Xu R, Deng L, Cai Y, Cong X, Yang Y, Hu S, Chen X.
    J Cell Biochem; 2008 Apr 15; 103(6):1718-31. PubMed ID: 17891781
    [Abstract] [Full Text] [Related]

  • 3. Reciprocal regulation of miR-23a and lysophosphatidic acid receptor signaling in cardiomyocyte hypertrophy.
    Yang J, Nie Y, Wang F, Hou J, Cong X, Hu S, Chen X.
    Biochim Biophys Acta; 2013 Aug 15; 1831(8):1386-94. PubMed ID: 23711961
    [Abstract] [Full Text] [Related]

  • 4. Proliferation of mouse endometrial stromal cells in culture is highly sensitive to lysophosphatidic acid signaling.
    Aikawa S, Kano K, Inoue A, Aoki J.
    Biochem Biophys Res Commun; 2017 Feb 26; 484(1):202-208. PubMed ID: 28073697
    [Abstract] [Full Text] [Related]

  • 5. Lysophosphatidic acid signaling via LPA1 and LPA3 regulates cellular functions during tumor progression in pancreatic cancer cells.
    Fukushima K, Takahashi K, Yamasaki E, Onishi Y, Fukushima N, Honoki K, Tsujiuchi T.
    Exp Cell Res; 2017 Mar 01; 352(1):139-145. PubMed ID: 28189636
    [Abstract] [Full Text] [Related]

  • 6. Lysophosphatidylethanolamine utilizes LPA(1) and CD97 in MDA-MB-231 breast cancer cells.
    Park SJ, Lee KP, Kang S, Chung HY, Bae YS, Okajima F, Im DS.
    Cell Signal; 2013 Nov 01; 25(11):2147-54. PubMed ID: 23838008
    [Abstract] [Full Text] [Related]

  • 7. LPA receptor1 antagonists as anticancer agents suppress human lung tumours.
    Zhao PF, Wu S, Li Y, Bao G, Pei JY, Wang YW, Ma Q, Sun HJ, Damirin A.
    Eur J Pharmacol; 2020 Feb 05; 868():172886. PubMed ID: 31866407
    [Abstract] [Full Text] [Related]

  • 8. Vascular smooth muscle migration and proliferation in response to lysophosphatidic acid (LPA) is mediated by LPA receptors coupling to Gq.
    Kim J, Keys JR, Eckhart AD.
    Cell Signal; 2006 Oct 05; 18(10):1695-701. PubMed ID: 16504475
    [Abstract] [Full Text] [Related]

  • 9. Lysophosphatidic Acid Receptor 1- and 3-Mediated Hyperalgesia and Hypoalgesia in Diabetic Neuropathic Pain Models in Mice.
    Ueda H, Neyama H, Matsushita Y.
    Cells; 2020 Aug 16; 9(8):. PubMed ID: 32824296
    [Abstract] [Full Text] [Related]

  • 10. LPA2 (EDG4) mediates Rho-dependent chemotaxis with lower efficacy than LPA1 (EDG2) in breast carcinoma cells.
    Chen M, Towers LN, O'Connor KL.
    Am J Physiol Cell Physiol; 2007 May 16; 292(5):C1927-33. PubMed ID: 17496233
    [Abstract] [Full Text] [Related]

  • 11. Lysophosphatidic acid promotes secretion of VEGF by increasing expression of 150-kD Oxygen-regulated protein (ORP150) in mesenchymal stem cells.
    Wei H, Wang F, Wang X, Yang J, Li Z, Cong X, Chen X.
    Biochim Biophys Acta; 2013 Aug 16; 1831(8):1426-34. PubMed ID: 23707263
    [Abstract] [Full Text] [Related]

  • 12. Melatonin promotes cardiomyocyte proliferation and heart repair in mice with myocardial infarction via miR-143-3p/Yap/Ctnnd1 signaling pathway.
    Ma WY, Song RJ, Xu BB, Xu Y, Wang XX, Sun HY, Li SN, Liu SZ, Yu MX, Yang F, Ye DY, Gong R, Han ZB, Yu Y, Bamba D, Wang N, Pan ZW, Cai BZ.
    Acta Pharmacol Sin; 2021 Jun 16; 42(6):921-931. PubMed ID: 32839503
    [Abstract] [Full Text] [Related]

  • 13. LPA1 receptor-mediated thromboxane A2 release is responsible for lysophosphatidic acid-induced vascular smooth muscle contraction.
    Dancs PT, Ruisanchez É, Balogh A, Panta CR, Miklós Z, Nüsing RM, Aoki J, Chun J, Offermanns S, Tigyi G, Benyó Z.
    FASEB J; 2017 Apr 16; 31(4):1547-1555. PubMed ID: 28069828
    [Abstract] [Full Text] [Related]

  • 14. Lysophosphatidic Acid Induces Ligamentum Flavum Hypertrophy Through the LPAR1/Akt Pathway.
    Zhou T, Du L, Chen C, Han C, Li X, Qin A, Zhao C, Zhang K, Zhao J.
    Cell Physiol Biochem; 2018 Apr 16; 45(4):1472-1486. PubMed ID: 29466791
    [Abstract] [Full Text] [Related]

  • 15. LPA2 Contributes to Vascular Endothelium Homeostasis and Cardiac Remodeling After Myocardial Infarction.
    Pei J, Cai L, Wang F, Xu C, Pei S, Guo H, Sun X, Chun J, Cong X, Zhu W, Zheng Z, Chen X.
    Circ Res; 2022 Aug 19; 131(5):388-403. PubMed ID: 35920162
    [Abstract] [Full Text] [Related]

  • 16. Differential targeting of lysophosphatidic acid LPA1, LPA2, and LPA3 receptor signalling by tricyclic and tetracyclic antidepressants.
    Olianas MC, Dedoni S, Onali P.
    Eur J Pharmacol; 2023 Nov 15; 959():176064. PubMed ID: 37758013
    [Abstract] [Full Text] [Related]

  • 17. LPA3 is a precise therapeutic target and potential biomarker for ovarian cancer.
    Zhao P, Yun Q, Li A, Li R, Yan Y, Wang Y, Sun H, Damirin A.
    Med Oncol; 2022 Jan 04; 39(2):17. PubMed ID: 34982278
    [Abstract] [Full Text] [Related]

  • 18. Lysophosphatidic Acid Inhibits Insulin Signaling in Primary Rat Hepatocytes via the LPA3 Receptor Subtype and is Increased in Obesity.
    Fayyaz S, Japtok L, Schumacher F, Wigger D, Schulz TJ, Haubold K, Gulbins E, Völler H, Kleuser B.
    Cell Physiol Biochem; 2017 Jan 04; 43(2):445-456. PubMed ID: 28922661
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic effect of a novel Wnt pathway inhibitor on cardiac regeneration after myocardial infarction.
    Yang D, Fu W, Li L, Xia X, Liao Q, Yue R, Chen H, Chen X, An S, Zeng C, Wang WE.
    Clin Sci (Lond); 2017 Dec 15; 131(24):2919-2932. PubMed ID: 29162747
    [Abstract] [Full Text] [Related]

  • 20. Antidepressants activate the lysophosphatidic acid receptor LPA(1) to induce insulin-like growth factor-I receptor transactivation, stimulation of ERK1/2 signaling and cell proliferation in CHO-K1 fibroblasts.
    Olianas MC, Dedoni S, Onali P.
    Biochem Pharmacol; 2015 Jun 15; 95(4):311-23. PubMed ID: 25888927
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.